Restenosis develops in four stages: Serial histologic studies in a coronary injury model  by Schwartz, Robert S. et al.
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Occlusive platelet-rich thrombi induced by 
intraluminal anodal stimulation of left anterior 
descending (LAD) coronary arteries in anesthetized, 
open-chest dogs were lysed with tissue plasminogen 
activator (rt-PA) (80 w/kg intravenously + 4 
ug/kg/min, 25 min after occlusion) with additionally 
(15 min before rt-PA): 1) solvent (S; n=S); 2) 
ridogrel, a combined thromboxane synthase inhibitor 
and receptor antagonist, (R; 5 mg/kg iv + 5 mg/kg/h; n 
= 5); heparin (H; 200 U/kg 2 x iv; n = 6); and 4) 
heparin + ridogrel (n = 6). Time to reperfusion (S = 
81; R = 65; H = 65; H + R = 24.5 min*l) median; P <O.OS 
*VS S; Wvs H), rt-PA consumed prior to reperfusion (S 
= 404; R = 340; H = 340; H + R = 17R ug/kg, p<O.O5 vs 
H), incidence of roocclusion within 120 min (S = 100%; 
R = 100%; H = 66%; H + R = 16.6%), time to reocclusion 
(S = 37; R = 29; H = 75.5; H + R = > 120 min*) and 
eventual thrombus mass (S = 49; R = 37; H = 7.5; H + R 
= 0 mg.1) were most affected by the heparin-ridogrel 
combination. These data demonstrate that the 
combination of ridogrel and heparin enhances the 
thrombolytic efficacy of rt-PA in this experimental 
model. 
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HEPARIN ENHANCES THROMBOLYSIS WITH II-PA 
, James H Chesebro, Mark WI Webster, Pierre 
Zoldhelyi, Diane E Grill, Valentin Fuster, Mayo Clinic, Rochester, 
MN. 
The coagulation cascade with thr0mbi.n generation is activated by 
thrombolysis. We compared the lytic effect (incidence of and time 
to reperfusion, residual thrombus by rrutologous “‘In-platelet 
deposition) of r&PA plus highdose heparin (100 U/kg, then 100 
U@/hr IV) with that of tt-PA alone in a porcine carotid model of 
platelet-rich, occlusive arterial thrombosis, created by balloon 
dilatation followed by atherectomy. rt-PA was administered as 0.3 
mg/kg bolus, 3 mgkg over 90 min, then 1 mgkg over 120 min. rt-PA 
plus heparin prolonged the activated partial thromboplastin time 
(APT 5.3kO.6 x basal, and was associated with major bleeding in 1 
Pig. ‘t In-labeled platelet deposition (per cm* of carotid artery) was 
measured after sacrifice at 210 min in all animals. 
No. reperfused/total pigs 
Time to reperfusion. min 
Platelet deposition, x106/cm2 
* mean 113 min 
n-PA rt-PA-theparin 
2/S 6R 
90,120 10,80,80,120,180,210 
X23*23 47t15 
Considerable mural thrombus remained in tbe artery after 210 min 
of therapy following successful reperfusion with heparin plus rt-PA 
In this model, thrombin inhibition with hirudin markedly enhanced 
thrombolysis with rt-PA 
APIT 24*0.1 x basal, ‘* I 
7n rep&used at 10-50 min [mean 33 min], 
In-platelet deposition 13~3 x lO%m*). 
Highdose heparin enhances thrombolysis with rt-PA, but is less 
effective *&an specific thrombin inhibition with hirudin. 
Roche.ster, h4innesottq 55905. 
times following deep coronary arteria1 injury. 
proiiferative, obstructive lesions. Stage I (6 hours) was 
characterized by a large, space occupying platelet-fibrin thrombus 
at the injury site. By 4 days (Stage II) the thromhus consisted of 
extensive fibrin clumps admixed with numerous erythrocytes, few 
intact platelets, and early endothelialization on the luminal 
surface. Stage III (7-14 days) was characterized by monocyte and 
lymphocyte infiltration, and by early ingrowth of medial smooth 
muscle cells (SMC). SMC mitoses were most prevalent at this 
time. In stage IV (14-28 days), SMC migration from 
formed a cap over the luminal side of the mass. 
downward growth of this cap resulted in the obstructive cellular 
lesion identical to that observed in human restenosis. 
If sintilar reparative processes cause human restenosis, 
solutions to the testenosis problem may lie in the interruption of 
one or more of these stages. 
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ULTRASTRUCTURE OF n~AN D PERIPTERAL 
ATREROHATOUS PLAQUES REWOVED BY PERCUTANEOUS ATRERECTOHY 
arrow cytoplasmic borders 
processes. Xetabolically active cellular organelles were 
seen only infrequently. ECH consisted of numerous 
collagen fibers with scattered atrix granules, lipid 
droplets and adjacent cholester 1 clefts. Peripheral 
lesions were characterized by less ECI, an increased 
number af cell with high secretory activity and a 
nucleus ratio. In cell culture studies 
with explanted tissue speci cellular outgrowth was 
seen to occur ignificantly (p<O.O2) earlier from 
peripheral than from coronary plaques (8.3 f 0.7 versus 
14.8 f 2.5 days, x f SD). 
Conclusions: In contra8 to our previous results from 
restenotic lesions, 
by large ECH regions 
coronary than in peripheral plaques. 
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